Interaction of haloperidol and ?-butyrolactone with (+)-amphetamine-induced changes in monoamine synthesis and metabolism in rat brain
- 1 June 1977
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 40 (2) , 129-147
- https://doi.org/10.1007/bf01250564
Abstract
The interaction of (+)-amphetamine with haloperidol andγ-butyrolactone on synthesis of monoamines in rat brain regions was investigated using anin vivo method, in which the accumulation of dopa and 5-hydroxytryptophan (5-HTP) was measured after inhibition of the aromatic amino acid decarboxylase by means of 3-hydroxybenzylhydrazine. The accumulation of 3-methoxytyramine (3-MT) after inhibition of the monoamine oxidase with pargyline was taken as an indicator of thein vivo release of dopamine (DA) into the extraneuronal space. (+)-Amphetamine at doses of 1-3 mg/kg caused an increase of dopa formation in the DA-rich areas c. striatum and mesolimbic forebrain but had no effect on dopa formation in neocortex and 5-HTP formation in all brain regions investigated. At a dose of 10 mg/kg (+)-amphetamine decreased dopa as well as 5-HTP formation in all brain regions studied. 3-MT accumulation in whole rat brain was stimulated by (+)-amphetamine as well as haloperidol and inhibited byγ-butyrolactone. Combined treatment with haloperidol and (+)-amphetamine not only potentiated the stimulation of dopa formation but also the increase of 3-MT accumulation. Pretreatment withγ-butyrolactone antagonized the stimulation of 3-MT formation induced by (+)-amphetamine at a dose of 10 mg/kg. This dose of (+)-amphetamine markedly counteracted theγ-butyroiactoneinduced increase in dopa formation especially in the DA-rich areas. The data support the view that impulse flow in DA neurons facilitates the effect of (+)-amphetamine on DA release and DA synthesis. Inhibition of catecholamine synthesis after high doses of (+)-amphetamine may be due to an increase in cytoplasmatic DA concentration causing end-product inhibition of tyrosine hydroxylase.This publication has 41 references indexed in Scilit:
- Drugs, Neurotransmitters, and SchizophreniaScience, 1974
- Amphetamine-induced inhibition of tyrosine hydroxylation in homogenates of rat corpus striatumJournal of Pharmacy and Pharmacology, 1973
- Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivoJournal of Pharmacy and Pharmacology, 1973
- Conjoint native and orthophthaldialdehyde-condensate assays for the fluorimetric determination of 5-hydroxyindoles in brainNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- Amphetamine-induced release of [3H]metaraminol from subcellular fractions of the mouse heartJournal of Pharmacy and Pharmacology, 1969
- Possible Functional Differentiation between the Stores from which Adrenergic Nerve Stimulation, Tyramine and Amphetamine Release NoradrenalineActa Physiologica Scandinavica, 1969
- Selective increase of brain dopamine induced by gamma-hydroxybutyrateLife Sciences, 1966
- Biochemical and Histochemical Studies on the Effects of Imipramine‐like Drugs and (+)‐Amphetamine on Central and Peripheral Catecholamine NeuronsActa Physiologica Scandinavica, 1966
- The effect of (+)-amphetamine on various central and peripheral catecholamine-containing neuronesJournal of Pharmacy and Pharmacology, 1966
- Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse BrainActa Pharmacologica et Toxicologica, 1963